AVI BIOPHARMA INC·4

Aug 25, 5:03 PM ET

JOHNSON GRAHAM 4

4 · AVI BIOPHARMA INC · Filed Aug 25, 2010

Insider Transaction Report

Form 4
Period: 2010-08-23
JOHNSON GRAHAM
Sr VP Preclinical Dev & Rsrch
Transactions
  • Award

    Stock Option (right to buy)

    2010-08-23+400,000400,000 total
    Exercise: $2.03Exp: 2020-08-23Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]The option vests in three equal annual installments beginning on 8/23/11.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT